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Nowadays 
disease represent a worldwide health threat. Rasagiline is one well-known medication for 
the treatment of Parkinson's disease, but more and cheaper alternatives are required.
1 
For 
this reason, our group is currently investigating a new catalytic asymmetric arylating
2
 
cyclization route - borylation-arylation-amination (BorArAm) (Scheme 1) giving useful 
potential lead compounds based on the rasagiline core structure for treating these diseases. 
Our results will be discussed in this communication. 
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Scheme 1: Reaction sequence for the synthesis of chiral bicyclic amines. 
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